"Annan Hospital" is one of Ever Supreme’s collaborating medical institution. It received approval by the Taiwan FDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell on January 13, 2020. " Autologous Dendritic cell (abbreviated as DC) treatment is available to patients who meet the conditions of admission with the following indications: Grade 1 to Grade 2 low-grade glioma and highly Grade 3 glioma, epithelial ovarian cancer, pancreatic cancer, prostate cancer, head and neck cancer, liver cancer, breast cancer, and colorectal cancer.
.jpg)